Persephoni BioPartners operates as both a venture studio and strategic consulting firm focused on transforming breakthrough science into high-impact biotech companies. Founded in 2024, the organization brings together a cross-functional leadership team with over 100 combined years of experience in life sciences research, FDA approvals, clinical advancement of 300+ therapies, and numerous M&A, IPO, and pharmaceutical partnership transactions. While Persephoni does not offer a formal named fellowship program, the organization provides emerging biotech professionals opportunities to engage with its venture studio operations and portfolio company development.

Persephoni's core mission centers on building an efficient, bold, and innovative venture studio that systematically transforms breakthrough science into high-impact biotech companies. The firm takes hands-on operational roles, providing strategic guidance and addressing challenges often overlooked in early-stage biotech ventures, including regulatory strategy, team building, clinical development planning, and fundraising support.